Further studies in NAFLD patients are needed to assess retinaldehyde in the liver and determine its relation with ALDH1A1 and ALDH1A3 expression as well as implications for the NAFLD pathogenesis. The gene discussed is ALDH1A3; the disease is metabolic dysfunction-associated steatotic liver disease.